Literature DB >> 33796968

Comparative outcomes of vascular access closure methods following atrial fibrillation/flutter catheter ablation: insights from VAscular Closure for Cardiac Ablation Registry.

Moghniuddin Mohammed1,2, Rigoberto Ramirez3, Daniel A Steinhaus4,5, Omair K Yousuf4,5, Michael J Giocondo4,5, Brian M Ramza4,5, Alan P Wimmer4,5, Sanjaya K Gupta6,7.   

Abstract

PURPOSE: This registry compared the safety and efficacy of vascular closure device Perclose (PC) with figure-of-eight stitch (Fo8) and manual compression (MC) following catheter ablation of atrial fibrillation/flutter.
METHODS: VAscular Closure for Cardiac Ablation Registry (VACCAR) is a prospective, observational registry that assessed the time to hemostasis (TTH), time to ambulation (TTA), length of stay (LOS), complications, patient-reported outcomes, and pain medication use.
RESULTS: A total of 434 patients (mean age 64.0±11.0 years; 38% female; 94.9% white) were enrolled between October 2017 and May 2019: 156 in MC, 203 in Fo8, and 75 in the PC group. Median TTH was significantly reduced in the PC and Fo8 group at 7 and 9 min respectively vs. the MC group at 20 min (p<0.001). Median TTA was significantly reduced in both the PC and Fo8 group at 2.2 h vs. the MC group at 6.5 h (p<0.001 for both). Median LOS for the PC group was significantly reduced at 27.5 h compared to the MC and Fo8 group at 29 h (p<0.01). A higher proportion of same-day discharges were noted in the PC and Fo8 groups at 14 (18.7%) and 25 (12.3%), respectively, compared to 5 (3.2%) in the MC group (p<0.01 for all). There was no significant difference in complications between the three groups.
CONCLUSIONS: Both PC and Fo8 are safe with improved TTH, TTA, LOS, and a higher number of same-day discharges compared to MC.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Figure-of-eight stitch; Manual compression; Vascular closure device

Mesh:

Year:  2021        PMID: 33796968     DOI: 10.1007/s10840-021-00981-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.759


  15 in total

1.  National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999-2013.

Authors:  James V Freeman; Yun Wang; Joseph Akar; Nihar Desai; Harlan Krumholz
Journal:  Circulation       Date:  2017-02-01       Impact factor: 29.690

2.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

3.  Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation.

Authors:  Sarah Traullé; Maciej Kubala; Alexandre Doucy; Serge Quenum; Jean-Sylvain Hermida
Journal:  Europace       Date:  2015-10-14       Impact factor: 5.214

4.  Comparison of standard vs modified "figure-of-eight" suture to achieve femoral venous hemostasis after cryoballoon based atrial fibrillation ablation.

Authors:  Hikmet Yorgun; Uğur Canpolat; Ahmet Hakan Ates; Metin Oksul; Yusuf Ziya Sener; Fatih Akkaya; Kudret Aytemir
Journal:  Pacing Clin Electrophysiol       Date:  2019-08-05       Impact factor: 1.976

5.  Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias.

Authors:  Marius Bohnen; William G Stevenson; Usha B Tedrow; Gregory F Michaud; Roy M John; Laurence M Epstein; Christine M Albert; Bruce A Koplan
Journal:  Heart Rhythm       Date:  2011-05-27       Impact factor: 6.343

6.  A randomized comparison of modified subcutaneous "Z"-stitch versus manual compression to achieve hemostasis after large caliber femoral venous sheath removal.

Authors:  Radoslaw Pracon; Sripal Bangalore; Jan Henzel; Iwona Cendrowska-Demkow; Barbara Pregowska-Chwala; Agnieszka Tarnowska; Zofia Dzielinska; Zbigniew Chmielak; Adam Witkowski; Marcin Demkow
Journal:  Catheter Cardiovasc Interv       Date:  2017-03-17       Impact factor: 2.692

7.  Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications.

Authors:  Sanghamitra Mohanty; Chintan Trivedi; Salwa Beheiry; Amin Al-Ahmad; Rodney Horton; Domenico G Della Rocca; Carola Gianni; Alessio Gasperetti; Mustafa Abdul-Moheeth; Mintu Turakhia; Andrea Natale
Journal:  Europace       Date:  2019-07-01       Impact factor: 5.214

Review 8.  Vascular closure devices for femoral arterial puncture site haemostasis.

Authors:  Lindsay Robertson; Alina Andras; Frances Colgan; Ralph Jackson
Journal:  Cochrane Database Syst Rev       Date:  2016-03-07

9.  Effect of catheter ablation on quality of life in patients with atrial fibrillation and its correlation with arrhythmia outcome.

Authors:  Daniel Raine; Philip Langley; Ewen Shepherd; Stephen Lord; Stephen Murray; Alan Murray; John P Bourke
Journal:  Open Heart       Date:  2015-09-10

10.  Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014.

Authors:  Gerhard Steinbeck; Moritz F Sinner; Manuel Lutz; Martina Müller-Nurasyid; Stefan Kääb; Holger Reinecke
Journal:  Eur Heart J       Date:  2018-12-01       Impact factor: 29.983

View more
  5 in total

Review 1.  Innovations in atrial fibrillation ablation.

Authors:  Jitae A Kim; Khurrum Khan; Riyad Kherallah; Shamis Khan; Ishan Kamat; Owais Ulhaq; Qussay Marashly; Mihail G Chelu
Journal:  J Interv Card Electrophysiol       Date:  2022-04-11       Impact factor: 1.900

2.  Femoral Vein Occlusion or Stenosis Using a Suture-Mediated Vascular Closure Device After Catheter Ablation.

Authors:  Hirofumi Arai; Takatoshi Shigeta; Yuichiro Sagawa; Atsuhito Oda; Koji Sudo; Karina Hara; Mitutoshi Asano; Tsukasa Shimura; Hidetoshi Suzuki; Manabu Kurabayashi; Hideki Arima; Satoshi Itoh; Masahiko Goya; Tetsuo Sasano; Yasuteru Yamauchi
Journal:  JACC Case Rep       Date:  2022-05-18

3.  Evaluating outcomes of same-day discharge after catheter ablation for atrial fibrillation in a real-world cohort.

Authors:  Michael E Field; Laura Goldstein; Kevin Corriveau; Rahul Khanna; Xiaozhou Fan; Michael R Gold
Journal:  Heart Rhythm O2       Date:  2021-07-14

Review 4.  Complications of the Percutaneous Mitral Valve Edge-To-Edge Repair: Role of Transesophageal Echocardiography.

Authors:  Guisela Flores; Dolores Mesa; Soledad Ojeda; Javier Suárez de Lezo; Rafael Gonzalez-Manzanares; Guillermo Dueñas; Manuel Pan
Journal:  J Clin Med       Date:  2022-08-14       Impact factor: 4.964

5.  Vascular Closure Devices versus Manual Compression in Cardiac Interventional Procedures: Systematic Review and Meta-Analysis.

Authors:  Naidong Pang; Jia Gao; Binghang Zhang; Min Guo; Nan Zhang; Meng Sun; Rui Wang
Journal:  Cardiovasc Ther       Date:  2022-09-09       Impact factor: 3.368

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.